Moleculin Biotech (FRA:MOL) Purchase Of Property, Plant, Equipment : €-0.11 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Moleculin Biotech Purchase Of Property, Plant, Equipment?

Moleculin Biotech's purchase of property, plant, equipment for the three months ended in Mar. 2024 was €0.00 Mil. It means Moleculin Biotech spent €0.00 Mil on purchasing property, plant, equipment. Moleculin Biotech's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.11Mil.

Compared with last quarter (€-0.07 Mil in Dec. 2023 ), Moleculin Biotech spent less money on purchasing property, plant, equipment in Mar. 2024 (€0.00 Mil).

Moleculin Biotech Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Moleculin Biotech's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moleculin Biotech Purchase Of Property, Plant, Equipment Chart

Moleculin Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Property, Plant, Equipment

Get a 7-Day Free Trial

-0.05

-0.31

-0.02

-0.06

-0.11

Moleculin Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Purchase Of Property, Plant, Equipment	Get a 7-Day Free Trial															-	-0.01	-0.03	-0.07	-

Moleculin Biotech Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.11 Mil.

Moleculin Biotech Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Moleculin Biotech's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Moleculin Biotech (FRA:MOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moleculin Biotech Inc (FRA:MOL) » Definitions » Purchase Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

MBRX:USA 0K2H:UK

Address

5300 Memorial Drive, Suite 950, Houston, TX, USA, 77007

Website

https://www.moleculin.com

Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.

Moleculin Biotech (FRA:MOL) Headlines

No Headlines